SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POETs sharp rebound after a steep selloff is driving attention, with bullish traders pointing to a recovery near the companys cash value and speculating about short covering. Others call it a temporary or fake pump and say sustained gains will require confirmed orders, shipments, or production updates; no specific new catalyst is established in the discussion.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

The discussion centers on pending top-line overall-survival results from SELLASs phase 3 REGAL trial of GPS, following the reported 80th-event milestone and the move into final analysis. Some traders anticipate favorable data and short covering, while others question the bullish case and point to the stocks sharp decline; the results remain unconfirmed.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. Its products include Gvoke, Keveyis, and Recorlev. Gvoke is a ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Xeris strong Q3 results, sharply growing Recorlev sales, and raised revenue outlook are driving the rally, with traders pointing to the improved long-term growth forecast as the main catalyst. The reaction is broadly bullish, while buyout and short-covering theories remain speculation rather than confirmed developments.

Firefly Aerospace, Inc. engages in the design and manufacture of space launch vehicles. The company was founded by Thomas E. Markusic, Mark Watt, and Max Polyakov in January 2017 and is headquartered in Leander, TX.

Firefly Aerospace Inc.

Fireflys multi-year engine, technology-licensing and engineering agreement with AST SpaceMobile is driving attention, with traders viewing it as validation of Fireflys propulsion business and a boost to its backlog and funding outlook. The reaction is broadly bullish, though some question the cash-versus-stock mix, possible dilution and how the deal will affect upcoming earnings.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQs quarterly reportshowing record results and a higher full-year revenue outlookis driving attention, with many traders celebrating the beat and stronger growth outlook. Others remain cautious about cash burn, dilution, and how much reported growth reflects acquisitions rather than the core quantum business.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

A sharp rebound after steep losses is drawing attention, with traders pointing to anticipation of NASAs CLPS 2.0 awards and a reported dismissal of a bid protest. The rally is widely welcomed, though traders debate whether it reflects short-covering and a space-sector bounce or a temporary relief move.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

INFQ is rebounding alongside quantum stocks, with traders pointing to Intels move to acquire a quantum company as a boost to sector sentiment and validation of the field. Some see room for short covering after the recent selloff, while others view the rise as a broader sector bounce rather than a new company-specific catalyst.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklos Q3 results and agreement to reserve U.S. Forged Rings manufacturing capacity for future Aurora reactors are driving attention alongside a sharp rebound after a prolonged selloff. Bulls see the supply-chain commitment and cash reserves as progress, while bears argue the company remains pre-revenue, richly valued, and exposed to dilution and long execution timelines.

Aduro Clean Technologies, Inc. engages in the manufacture of oils and specialty chemicals using waste plastics. It focuses on hydrochemolytic technology to transform post-consumer polymer waste into a resource for the circular economy. It also develops a novel chemical conversion process to transform waste plastics and low grade renewable oils into renewable fuels and specialty chemicals. The company was founded on January 10, 2018 by Ofer Vicus and William Marcus Trygstad and is headquartered in London, Canada.

Aduro Clean Technologies Inc

Aduros 120-hour pilot campaign, which included processing real post-consumer plastic and met its condensable-hydrocarbon yield target, is a focus of discussion alongside the stocks sharp move and increased volume. Bulls see progress toward validating HCT, while skeptics argue that pilot results do not establish viable economics or commercial readiness.

Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company. It engages in developing, manufacturing, and commercializing drug-device combination products using advanced auto-injector technology that are designed to provide commercial or functional advantages such as improved convenience and tolerability, and enhanced patient comfort and adherence. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA.

Halozyme Therapeutics Inc.

Halozyme Therapeutics is seeing significant investor attention following its decision to withdraw a contentious acquisition bid, a move that the market has interpreted as a commitment to fiscal discipline. Investors are now shifting their focus toward the company's core royalty-driven business model, strong earnings growth, and upcoming catalysts like new patent extensions and high-volume autoinjector partnerships.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Corgi ETF Trust I. - Corgi OKLO 2x Daily ETF

Neutral Sentiment

Up more than 1% 

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$3.72
Prev Close	$2.62
Open	$3.12
Dividend Yield	N/A
50-Day Moving Average	$9.14
Beta	N/A
Avg. Volume	6,684.99
PE Ratio	N/A

52-Week High	$22.84
52-Week Low	$2.47
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

OKLC Fundamentals